Angiex (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$18,000,221
Company Info
Founders
Marty Duvall
Market
Healthcare & Wellness
Coinvestors
Nudel Holdings,Presight Capital
Company Description

A developer of vascular-targeted biotherapeutics designed to treat cancer. Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement